Altogether, our data suggested that Bmi1 inhibition might promote the release of cytochrome c into the cytosol in gemcitabine-treated pancreatic cancer cells, leading to apoptotic cascade at least in part by enhancing ROS production. This evidence concerns the gene CYCS and familial pancreatic carcinoma.